CGEN
Compugen Ltd
Price:  
1.76 
USD
Volume:  
94,601.00
Israel | Life Sciences Tools & Services
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CGEN EV/EBITDA

-210.6%
Upside

As of 2025-07-04, the EV/EBITDA ratio of Compugen Ltd (CGEN) is -10.00. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. CGEN's latest enterprise value is 143.02 mil USD. CGEN's TTM EBITDA according to its financial statements is -14.31 mil USD. Dividing these 2 quantities gives us the above CGEN EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 11.6x - 14.5x 12.0x
Forward P/E multiples 12.5x - 16.3x 14.4x
Fair Price (1.84) - (2.16) (1.95)
Upside -204.4% - -222.8% -210.6%
1.76 USD
Stock Price
(1.95) USD
Fair Price

CGEN EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-03-03 -10.31
2025-02-28 -11.00
2025-02-27 -10.56
2025-02-26 -11.18
2025-02-25 -11.12
2025-02-24 -11.94
2025-02-21 -12.12
2025-02-20 -12.62
2025-02-19 -12.94
2025-02-18 -13.25
2025-02-14 -12.87
2025-02-13 -12.69
2025-02-12 -12.69
2025-02-11 -12.44
2025-02-10 -14.13
2025-02-07 -15.06
2025-02-06 -14.75
2025-02-05 -15.06
2025-02-04 -13.81
2025-02-03 -13.37
2025-01-31 -13.56
2025-01-30 -13.69
2025-01-29 -13.56
2025-01-28 -13.31
2025-01-27 -13.12
2025-01-24 -14.19
2025-01-23 -14.44
2025-01-22 -13.88
2025-01-21 -13.19
2025-01-17 -13.06
2025-01-16 -12.25
2025-01-15 -11.56
2025-01-14 -11.50
2025-01-13 -11.43
2025-01-10 -9.24
2025-01-08 -8.93
2025-01-07 -8.99
2025-01-06 -8.99
2025-01-03 -8.99
2025-01-02 -9.31
2024-12-31 -8.56
2024-12-30 -8.37
2024-12-27 -8.81
2024-12-26 -9.18
2024-12-24 -8.99
2024-12-23 -8.49
2024-12-20 -8.56
2024-12-19 -8.49
2024-12-18 -8.43
2024-12-17 -8.93